Cost effectiveness of screening and statin therapy in clinical guidelines for cardiovascular prophylaxis

被引：0
|
作者：
Milne, RJ [1 ]
Gamble, GD [1 ]
机构：
[1] Univ Auckland, Auckland 1, New Zealand
来源：
VALUE IN HEALTH | 2004年 / 7卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)62091-8
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：228 / 228
页数：1
相关论文
共 50 条
  • [31] Cost-effectiveness of statin monotherapy and combination therapy with ezetimibe.
    Coleman, CI
    Gillespie, EL
    Gryskiewicz, KA
    White, M
    PHARMACOTHERAPY, 2005, 25 (03): : 470 - 470
  • [32] Cost-effectiveness analysis of national clinical guidelines
    Van Os, N
    Niessen, LW
    Casparie, AF
    Van Hout, BA
    DIABETES, 1999, 48 : A416 - A416
  • [33] COST-EFFECTIVENESS OF LDL-P-GUIDED STATIN THERAPY
    Folse, H. J.
    Rengarajan, B.
    Goswami, D.
    Budoff, M.
    Kahn, R.
    VALUE IN HEALTH, 2014, 17 (07) : A491 - A491
  • [34] Clinical implications of the AHA preparticipation cardiovascular screening guidelines
    McGrew, CA
    ATHLETIC THERAPY TODAY, 2000, 5 (04): : 52 - 56
  • [35] A Reappraisal of the Safety and Cost-Effectiveness of Statin Therapy in Primary Prevention
    Bleakley, Caroline
    Pumb, Richard
    Harbinson, Mark
    McVeigh, Gary Eugene
    CANADIAN JOURNAL OF CARDIOLOGY, 2015, 31 (12) : 1411 - 1414
  • [36] Cost effectiveness analysis of therapy modification after failing statin treatment
    Grauer, DW
    Franic, DM
    Sullins, G
    VALUE IN HEALTH, 2004, 7 (03) : 326 - 327
  • [37] Cost-effectiveness of 10-Year Risk Thresholds for Initiation of Statin Therapy for Primary Prevention of Cardiovascular Disease
    Pandya, Ankur
    Sy, Stephen
    Cho, Sylvia
    Weinstein, Milton C.
    Gaziano, Thomas A.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2015, 314 (02): : 142 - 150
  • [38] Cost-effectiveness of routine screening for statin-induced hepatitis.
    Lehmann, DF
    Connell, R
    Newman, N
    Shanahan, P
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 65 (02) : 182 - 182
  • [39] Cost effectiveness of population screening vs. no screening for cardiovascular disease: the Danish Cardiovascular Screening trial (DANCAVAS)
    Sogaard, Rikke
    Diederichsen, Axel Cosmus Pyndt
    Rasmussen, Lars M.
    Lambrechtsen, Jess
    Steffensen, Flemming H.
    Frost, Lars
    Egstrup, Kenneth
    Urbonaviciene, Grazina
    Busk, Martin
    Lindholt, Jes S.
    EUROPEAN HEART JOURNAL, 2022, 43 (41) : 4392 - 4402
  • [40] DRIVERS OF COST-EFFECTIVENESS OF CAC-GUIDED STATIN THERAPY UNDER 2019 ACC/AHA PRIMARY PREVENTION GUIDELINES
    Venkataraman, Prasanna
    Huynh, Quan
    Marwick, Thomas H.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 1934 - 1934
12345